These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25149909)

  • 21. Mutagenesis studies toward understanding the mechanism of the cofactor function of thrombomodulin.
    Rezaie AR; Yang L
    Biophys Chem; 2005 Oct; 117(3):255-61. PubMed ID: 15970373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gly74Ser mutation in protein C causes thrombosis due to a defect in protein S-dependent anticoagulant function.
    Chen C; Yang L; Villoutreix BO; Wang X; Ding Q; Rezaie AR
    Thromb Haemost; 2017 Jun; 117(7):1358-1369. PubMed ID: 28405673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombomodulin protects endothelial cells from a calcineurin inhibitor-induced cytotoxicity by upregulation of extracellular signal-regulated kinase/myeloid leukemia cell-1 signaling.
    Ikezoe T; Yang J; Nishioka C; Honda G; Furihata M; Yokoyama A
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2259-70. PubMed ID: 22796578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved distinction of factor V wild-type and factor V Leiden using a novel prothrombin-based activated protein C resistance assay.
    Wilmer M; Stocker C; Bühler B; Conell B; Calatzis A
    Am J Clin Pathol; 2004 Dec; 122(6):836-42. PubMed ID: 15539375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in autolytic loop-2 and at Asp554 of human prothrombin that enhance protein C activation by meizothrombin.
    Koike H; Okuda D; Morita T
    J Biol Chem; 2003 Apr; 278(17):15015-22. PubMed ID: 12588872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological Differentiation of Thrombomodulin Alfa and Activated Protein C on Coagulation and Fibrinolysis In Vitro.
    Tanaka K; Tawara S; Tsuruta K; Hoppensteadt D; Fareed J
    Clin Appl Thromb Hemost; 2018 Sep; 24(6):859-866. PubMed ID: 29683037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased tissue factor-initiated prothrombin activation as a result of the Arg506 --> Gln mutation in factor VLEIDEN.
    van 't Veer C; Kalafatis M; Bertina RM; Simioni P; Mann KG
    J Biol Chem; 1997 Aug; 272(33):20721-9. PubMed ID: 9252393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening and functional exploration of prothrombin Arg596 related mutations in Chinese venous thromboembolism patients.
    Wu X; Li L; Ding Q; Wang X; Wu F; Wu W
    J Clin Pathol; 2018 Jul; 71(7):614-619. PubMed ID: 29331940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble thrombomodulin is antithrombotic in the presence of neutralising antibodies to protein C and reduces circulating activated protein C levels in primates.
    Tanaka KA; Fernández JA; Marzec UM; Kelly AB; Mohri M; Griffin JH; Hanson SR; Gruber A
    Br J Haematol; 2006 Jan; 132(2):197-203. PubMed ID: 16398653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutation of protease domain residues Lys37-39 in human protein C inhibits activation by the thrombomodulin-thrombin complex without affecting activation by free thrombin.
    Gerlitz B; Grinnell BW
    J Biol Chem; 1996 Sep; 271(37):22285-8. PubMed ID: 8798383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localization of the single-stranded DNA binding site in the thrombin anion-binding exosite.
    Wu Q; Tsiang M; Sadler JE
    J Biol Chem; 1992 Dec; 267(34):24408-12. PubMed ID: 1332957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in coagulation and hemodynamics during pregnancy: a prospective longitudinal study of 58 cases.
    Hui C; Lili M; Libin C; Rui Z; Fang G; Ling G; Jianping Z
    Arch Gynecol Obstet; 2012 May; 285(5):1231-6. PubMed ID: 22083312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and functional characterization of a natural homozygous Arg67His mutation in the prothrombin gene of a patient with a severe procoagulant defect contrasting with a mild hemorrhagic phenotype.
    Akhavan S; De Cristofaro R; Peyvandi F; Lavoretano S; Landolfi R; Mannucci PM
    Blood; 2002 Aug; 100(4):1347-53. PubMed ID: 12149217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating activated protein C levels are not increased in septic patients treated with recombinant human soluble thrombomodulin.
    Arishima T; Ito T; Yasuda T; Yashima N; Furubeppu H; Kamikokuryo C; Futatsuki T; Madokoro Y; Miyamoto S; Eguchi T; Haraura H; Maruyama I; Kakihana Y
    Thromb J; 2018; 16():24. PubMed ID: 30275773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced protein C activation and inhibition of fibrinogen cleavage by a thrombin modulator.
    Berg DT; Wiley MR; Grinnell BW
    Science; 1996 Sep; 273(5280):1389-91. PubMed ID: 8703074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prothrombin Arg541Trp Mutation Leads to Defective PC (Protein C) Pathway Activation and Constitutes a Novel Genetic Risk Factor for Venous Thrombosis.
    Wu X; Dai J; Xu X; Li F; Li L; Lu Y; Xu Q; Ding Q; Wu W; Wang X
    Arterioscler Thromb Vasc Biol; 2020 Feb; 40(2):483-494. PubMed ID: 31875702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How Thrombomodulin Enables W215A/E217A Thrombin to Cleave Protein C but Not Fibrinogen.
    Peacock RB; McGrann T; Zaragoza S; Komives EA
    Biochemistry; 2022 Jan; 61(2):77-84. PubMed ID: 34978431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probing the activation of protein C by the thrombin-thrombomodulin complex using structural analysis, site-directed mutagenesis, and computer modeling.
    Knobe KE; Berntsdotter A; Shen L; Morser J; Dahlbäck B; Villoutreix BO
    Proteins; 1999 May; 35(2):218-34. PubMed ID: 10223294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New Prothrombin Mutation (Arg596Trp, Prothrombin Padua 2) Associated With Venous Thromboembolism.
    Bulato C; Radu CM; Campello E; Gavasso S; Spiezia L; Tormene D; Simioni P
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):1022-9. PubMed ID: 27013614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.